Suchergebnisse - "Dogné, Jean-Michel"

PubPharm (334)

51

Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Favresse, J. | Bayart, J. | Mullier, F. | +3

52

Waning of IgG, total and neutralizing antibodies 6 months post-vaccination with BNT162b2 in healthcare workers

enthalten in: ResearchSquare.com | 2021

von Bayart, J. | Douxfils, J. | Gillot, C. | +12

53

Efficient Maternal to Neonate Transfer of Neutralizing Antibodies after SARS-CoV-2 Vaccination with BNT162b2 : A Case-Report and Discussion of the Literature

enthalten in: Vaccines | 2021

von Douxfils, J. | Gillot, C. | De Gottal, �. | +4

54

Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins - a rational for monitoring immunoglobulin G levels

enthalten in: Haematologica | 2021

von Douxfils, J. | Vayne, C. | Pouplard, C. | +9

55

Assessment of acquired activated protein C resistance with the FibWave and comparison with the ETP-based APC resistance

enthalten in: International journal of laboratory hematology | 2021

von Evrard, J. | Morimont, L. | Didembourg, M. | +4

56

Authors’ Reply to Braillon and Martin’s Comment on “Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)”

enthalten in: Drug safety | 2021

von Bahri, P. | Morales, D. | Inoubli, A. | +2

57

Authors’ Reply to Braillon and Martin’s Comment on “Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)”

enthalten in: Drug safety | 2021

von Bahri, P. | Morales, D. | Inoubli, A. | +2

58

Authors’ Reply to Braillon and Martin’s Comment on “Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)”

enthalten in: Drug safety | 2021

von Bahri, P. | Morales, D. | Inoubli, A. | +2

59

Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination

enthalten in: Thrombosis research | 2021

von Douxfils, J. | Favresse, J. | Dogné, J. | +11

60

Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2

enthalten in: Viruses | 2021

von Favresse, J. | Gillot, C. | Di Chiaro, L. | +7